Table S3 from Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures

Table S3 from Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures

<p>Supplementary Table 3 binarization sensitivity 19 drugs</p>

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Stephen H. Chang (16814996) (author)
مؤلفون آخرون: Ryan J. Ice (16814999) (author), Michelle Chen (16815002) (author), Maxim Sidorov (16815005) (author), Rinette W.L. Woo (16815008) (author), Aida Rodriguez-Brotons (16815011) (author), Damon Jian (16815014) (author), Han Kyul Kim (16815017) (author), Angela Kim (16815020) (author), David E. Stone (16815023) (author), Ari Nazarian (16815026) (author), Alyssia Oh (16815029) (author), Gregory J. Tranah (16815032) (author), Mehdi Nosrati (14952166) (author), David de Semir (16815035) (author), Altaf A. Dar (16815038) (author), Pierre-Yves Desprez (16815041) (author), Mohammed Kashani-Sabet (14952178) (author), Liliana Soroceanu (16815044) (author), Sean D. McAllister (16815047) (author)
منشور في: 2025
الموضوعات:
Cancer
Therapeutic Research and Development
Clinical Research and Trials
Methods and Technology
Drug Discovery Technologies
Computational methods
Drug Targets
Pharmacology
Pharmacogenetics/pharmacogenomics
Precision Medicine
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
كن أول من يترك تعليقا!
يجب تسجيل دخولك أولا

مواد مشابهة